An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Ariel Fernández(Rice University), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center)
Cited by 161
Related Papers
Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer
|Cell Discovery|2017|39
PKC<i>δ</i>Regulates Translation Initiation through PKR and eIF2<i>α</i>in Response to Retinoic Acid in Acute Myeloid Leukemia Cells
|Leukemia Research and Treatment|2012|10